Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adolescent Medicine | 14 | 2020 | 72 | 1.980 |
Why?
|
Adolescent Health Services | 13 | 2015 | 215 | 1.470 |
Why?
|
Vaginal Smears | 10 | 2003 | 511 | 1.210 |
Why?
|
Contraceptives, Oral, Hormonal | 4 | 2014 | 188 | 0.920 |
Why?
|
Polycystic Ovary Syndrome | 8 | 2014 | 370 | 0.900 |
Why?
|
Sexual Behavior | 23 | 2018 | 2057 | 0.830 |
Why?
|
Mentors | 5 | 2018 | 631 | 0.820 |
Why?
|
Faculty, Medical | 8 | 2022 | 1181 | 0.730 |
Why?
|
Sexually Transmitted Diseases | 15 | 2015 | 624 | 0.690 |
Why?
|
Adolescent Behavior | 15 | 2003 | 1151 | 0.670 |
Why?
|
Child Abuse, Sexual | 11 | 1999 | 383 | 0.650 |
Why?
|
Counseling | 3 | 2014 | 1523 | 0.600 |
Why?
|
Contraceptives, Oral | 12 | 2000 | 564 | 0.590 |
Why?
|
Contraceptive Devices, Female | 2 | 2014 | 43 | 0.540 |
Why?
|
Maternal-Child Health Centers | 1 | 2015 | 40 | 0.510 |
Why?
|
Education, Public Health Professional | 1 | 2015 | 24 | 0.510 |
Why?
|
Academic Medical Centers | 5 | 2022 | 2759 | 0.490 |
Why?
|
Interdisciplinary Communication | 2 | 2011 | 950 | 0.480 |
Why?
|
Adolescent | 115 | 2021 | 85781 | 0.480 |
Why?
|
Transdermal Patch | 1 | 2014 | 51 | 0.480 |
Why?
|
Contraception Behavior | 4 | 2014 | 185 | 0.480 |
Why?
|
Career Mobility | 3 | 2017 | 262 | 0.470 |
Why?
|
Leadership | 3 | 2021 | 1357 | 0.460 |
Why?
|
Sex Education | 6 | 2019 | 93 | 0.460 |
Why?
|
Contraception | 3 | 2018 | 359 | 0.460 |
Why?
|
Physical Examination | 13 | 2007 | 1237 | 0.450 |
Why?
|
Menarche | 7 | 2010 | 516 | 0.450 |
Why?
|
Pregnancy in Adolescence | 10 | 2000 | 158 | 0.440 |
Why?
|
Pelvic Inflammatory Disease | 6 | 2003 | 94 | 0.420 |
Why?
|
Health Knowledge, Attitudes, Practice | 12 | 2019 | 3923 | 0.420 |
Why?
|
Menorrhagia | 2 | 2007 | 63 | 0.410 |
Why?
|
Professional Competence | 1 | 2015 | 447 | 0.400 |
Why?
|
Patient Compliance | 9 | 2003 | 2684 | 0.390 |
Why?
|
Hymen | 4 | 1994 | 16 | 0.360 |
Why?
|
Risk-Taking | 9 | 2015 | 986 | 0.360 |
Why?
|
Hyperandrogenism | 2 | 2008 | 38 | 0.350 |
Why?
|
Pediatrics | 11 | 2018 | 3475 | 0.340 |
Why?
|
Hepatitis B Vaccines | 2 | 2001 | 194 | 0.340 |
Why?
|
Uterine Cervical Dysplasia | 3 | 2003 | 387 | 0.330 |
Why?
|
Staff Development | 2 | 2018 | 223 | 0.300 |
Why?
|
Cystic Fibrosis | 3 | 2019 | 1177 | 0.300 |
Why?
|
Contraceptive Agents, Female | 1 | 2008 | 135 | 0.290 |
Why?
|
Puberty | 7 | 2009 | 490 | 0.280 |
Why?
|
Sexual Partners | 5 | 2015 | 730 | 0.270 |
Why?
|
Amenorrhea | 6 | 1997 | 485 | 0.260 |
Why?
|
Female | 122 | 2020 | 380194 | 0.260 |
Why?
|
Preventive Medicine | 2 | 2003 | 264 | 0.240 |
Why?
|
Vulvovaginitis | 3 | 1993 | 16 | 0.230 |
Why?
|
Pelvis | 6 | 2000 | 730 | 0.230 |
Why?
|
Continuity of Patient Care | 2 | 2003 | 1049 | 0.230 |
Why?
|
Teaching | 3 | 2019 | 1174 | 0.230 |
Why?
|
Education, Medical | 3 | 2014 | 1721 | 0.220 |
Why?
|
Curriculum | 7 | 2018 | 3605 | 0.220 |
Why?
|
Internship and Residency | 10 | 2018 | 5788 | 0.220 |
Why?
|
Fellowships and Scholarships | 5 | 2017 | 1076 | 0.210 |
Why?
|
Anorexia Nervosa | 8 | 2002 | 1286 | 0.210 |
Why?
|
Levonorgestrel | 4 | 2003 | 77 | 0.210 |
Why?
|
Condoms | 5 | 2001 | 323 | 0.210 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2003 | 2020 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Humans | 141 | 2023 | 744343 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Hospitals, Pediatric | 4 | 2009 | 1775 | 0.200 |
Why?
|
Menstruation Disturbances | 5 | 1997 | 148 | 0.200 |
Why?
|
Confidentiality | 2 | 2008 | 612 | 0.200 |
Why?
|
Uterine Hemorrhage | 3 | 1999 | 255 | 0.190 |
Why?
|
Hepatitis B Antibodies | 1 | 2001 | 159 | 0.190 |
Why?
|
Boston | 13 | 2017 | 9313 | 0.190 |
Why?
|
Safe Sex | 1 | 2001 | 141 | 0.180 |
Why?
|
Gonorrhea | 5 | 2003 | 335 | 0.180 |
Why?
|
Ovary | 4 | 2014 | 981 | 0.180 |
Why?
|
Bacteriuria | 3 | 1991 | 102 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
Impulsive Behavior | 1 | 2002 | 316 | 0.180 |
Why?
|
Vulva | 2 | 1992 | 87 | 0.170 |
Why?
|
Needs Assessment | 3 | 2019 | 1147 | 0.170 |
Why?
|
Menstrual Cycle | 5 | 2010 | 551 | 0.170 |
Why?
|
Medroxyprogesterone Acetate | 3 | 2008 | 162 | 0.170 |
Why?
|
Interdisciplinary Studies | 2 | 2019 | 89 | 0.170 |
Why?
|
Patient Care Team | 1 | 2010 | 2531 | 0.160 |
Why?
|
Growth | 4 | 2001 | 376 | 0.160 |
Why?
|
Nutritional Physiological Phenomena | 3 | 2002 | 370 | 0.160 |
Why?
|
Physicians, Women | 3 | 2009 | 486 | 0.160 |
Why?
|
Child | 46 | 2022 | 77709 | 0.150 |
Why?
|
Tumor Virus Infections | 3 | 2003 | 452 | 0.150 |
Why?
|
Attitude to Health | 4 | 2001 | 2052 | 0.150 |
Why?
|
Preventive Health Services | 2 | 2001 | 575 | 0.140 |
Why?
|
Thrombosis | 1 | 2011 | 2968 | 0.140 |
Why?
|
Women | 1 | 2018 | 230 | 0.140 |
Why?
|
Antimalarials | 1 | 2023 | 905 | 0.140 |
Why?
|
Sexual Maturation | 1 | 1998 | 265 | 0.140 |
Why?
|
Metformin | 1 | 2023 | 835 | 0.140 |
Why?
|
Schools, Medical | 3 | 2022 | 880 | 0.140 |
Why?
|
Menstruation | 4 | 2009 | 302 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3843 | 0.130 |
Why?
|
Coitus | 2 | 1995 | 133 | 0.130 |
Why?
|
Anovulation | 2 | 1994 | 58 | 0.130 |
Why?
|
United States | 22 | 2021 | 69872 | 0.130 |
Why?
|
Precancerous Conditions | 2 | 2001 | 975 | 0.130 |
Why?
|
Communication Aids for Disabled | 1 | 1995 | 56 | 0.130 |
Why?
|
Chlamydia Infections | 3 | 2003 | 365 | 0.130 |
Why?
|
Pelvic Pain | 1 | 1997 | 274 | 0.130 |
Why?
|
Genitalia, Female | 3 | 1992 | 146 | 0.130 |
Why?
|
Vaginitis | 4 | 2003 | 47 | 0.130 |
Why?
|
Health Maintenance Organizations | 1 | 1998 | 642 | 0.130 |
Why?
|
Gymnastics | 2 | 1993 | 26 | 0.130 |
Why?
|
Menstrual Hygiene Products | 1 | 1994 | 18 | 0.120 |
Why?
|
Health Behavior | 4 | 2001 | 2636 | 0.120 |
Why?
|
Vagina | 3 | 1990 | 825 | 0.120 |
Why?
|
Vitamin D Deficiency | 1 | 2004 | 1343 | 0.120 |
Why?
|
Gardnerella vaginalis | 2 | 1991 | 13 | 0.120 |
Why?
|
Progesterone Congeners | 2 | 2011 | 42 | 0.120 |
Why?
|
Logistic Models | 6 | 2012 | 13408 | 0.120 |
Why?
|
Research Support as Topic | 2 | 2009 | 705 | 0.120 |
Why?
|
Hepatitis B | 1 | 1999 | 695 | 0.120 |
Why?
|
Health Personnel | 3 | 2019 | 3218 | 0.120 |
Why?
|
Adult | 52 | 2018 | 214055 | 0.120 |
Why?
|
Hirsutism | 4 | 1996 | 69 | 0.120 |
Why?
|
Goals | 3 | 2015 | 706 | 0.120 |
Why?
|
Rape | 2 | 1998 | 133 | 0.120 |
Why?
|
Health Education | 1 | 2000 | 1056 | 0.120 |
Why?
|
Mass Screening | 5 | 2002 | 5255 | 0.110 |
Why?
|
Endometriosis | 2 | 1997 | 839 | 0.110 |
Why?
|
Medical History Taking | 3 | 2019 | 783 | 0.110 |
Why?
|
Videotape Recording | 3 | 2001 | 352 | 0.110 |
Why?
|
Hospitalists | 1 | 2017 | 305 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 3 | 2003 | 392 | 0.110 |
Why?
|
Private Sector | 1 | 2015 | 392 | 0.110 |
Why?
|
Chlamydia trachomatis | 2 | 1991 | 246 | 0.100 |
Why?
|
Norethindrone | 1 | 1992 | 59 | 0.100 |
Why?
|
Women, Working | 1 | 2012 | 87 | 0.100 |
Why?
|
Pyuria | 1 | 1991 | 30 | 0.100 |
Why?
|
Fertility | 2 | 2018 | 781 | 0.100 |
Why?
|
Data Collection | 5 | 2001 | 3341 | 0.100 |
Why?
|
Colposcopy | 3 | 1997 | 144 | 0.100 |
Why?
|
Women's Health | 1 | 2000 | 2034 | 0.100 |
Why?
|
Insurance Claim Review | 1 | 2015 | 720 | 0.100 |
Why?
|
Program Evaluation | 2 | 2015 | 2488 | 0.090 |
Why?
|
Oligomenorrhea | 2 | 1980 | 45 | 0.090 |
Why?
|
Estrogens, Conjugated (USP) | 4 | 1997 | 275 | 0.090 |
Why?
|
Vitamin D | 1 | 2004 | 3223 | 0.090 |
Why?
|
Bone Density | 4 | 2002 | 3468 | 0.090 |
Why?
|
Vaginosis, Bacterial | 1 | 1991 | 128 | 0.090 |
Why?
|
Music | 3 | 1998 | 263 | 0.090 |
Why?
|
Dehydroepiandrosterone | 2 | 2002 | 252 | 0.090 |
Why?
|
Cross-Sectional Studies | 8 | 2015 | 25043 | 0.090 |
Why?
|
Dexamethasone | 3 | 2000 | 1951 | 0.080 |
Why?
|
Salaries and Fringe Benefits | 1 | 2011 | 264 | 0.080 |
Why?
|
Estrogens | 2 | 1994 | 1566 | 0.080 |
Why?
|
Neisseria gonorrhoeae | 1 | 1991 | 238 | 0.080 |
Why?
|
Violence | 5 | 1998 | 909 | 0.080 |
Why?
|
Program Development | 1 | 2015 | 1316 | 0.080 |
Why?
|
Papillomaviridae | 3 | 2003 | 1119 | 0.080 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2009 | 113 | 0.080 |
Why?
|
Esterases | 1 | 1987 | 95 | 0.080 |
Why?
|
Age Factors | 8 | 2015 | 18370 | 0.080 |
Why?
|
Clinical Enzyme Tests | 1 | 1987 | 115 | 0.080 |
Why?
|
Patient Access to Records | 1 | 2008 | 118 | 0.070 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2291 | 0.070 |
Why?
|
Massachusetts | 5 | 2015 | 8663 | 0.070 |
Why?
|
Vaccination | 1 | 1999 | 3278 | 0.070 |
Why?
|
Hypothalamic Hormones | 1 | 2008 | 147 | 0.070 |
Why?
|
Axilla | 1 | 2009 | 595 | 0.070 |
Why?
|
Prejudice | 2 | 2009 | 570 | 0.070 |
Why?
|
Male | 31 | 2020 | 350118 | 0.070 |
Why?
|
Wilms Tumor | 1 | 2009 | 373 | 0.070 |
Why?
|
Sports Medicine | 1 | 1989 | 225 | 0.070 |
Why?
|
Adrenal Hyperplasia, Congenital | 2 | 1984 | 98 | 0.070 |
Why?
|
Osteoporosis | 3 | 2008 | 1580 | 0.070 |
Why?
|
Research Personnel | 2 | 2009 | 573 | 0.070 |
Why?
|
Young Adult | 7 | 2020 | 56430 | 0.070 |
Why?
|
Hypogonadism | 2 | 1990 | 799 | 0.070 |
Why?
|
Saliva | 1 | 2010 | 809 | 0.070 |
Why?
|
Estrogen Replacement Therapy | 2 | 2002 | 1203 | 0.070 |
Why?
|
Progesterone | 1 | 2010 | 776 | 0.070 |
Why?
|
Trace Elements | 1 | 2007 | 198 | 0.070 |
Why?
|
Longitudinal Studies | 3 | 2015 | 13989 | 0.060 |
Why?
|
Congresses as Topic | 1 | 2010 | 764 | 0.060 |
Why?
|
Sex Factors | 7 | 2017 | 10397 | 0.060 |
Why?
|
Television | 2 | 1998 | 409 | 0.060 |
Why?
|
Parents | 1 | 2018 | 3407 | 0.060 |
Why?
|
Health Care Surveys | 2 | 2003 | 2453 | 0.060 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2000 | 648 | 0.060 |
Why?
|
Sensitivity and Specificity | 6 | 2014 | 14722 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.060 |
Why?
|
Ethyl Ethers | 1 | 2023 | 20 | 0.060 |
Why?
|
Pregnancy | 13 | 2000 | 29144 | 0.060 |
Why?
|
Contraceptive Devices | 1 | 2003 | 24 | 0.060 |
Why?
|
Cosyntropin | 1 | 1983 | 33 | 0.060 |
Why?
|
Steroid Hydroxylases | 1 | 1983 | 96 | 0.060 |
Why?
|
Psychosexual Development | 1 | 1983 | 20 | 0.060 |
Why?
|
Ethers | 1 | 2023 | 75 | 0.060 |
Why?
|
Predictive Value of Tests | 7 | 2003 | 15076 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2007 | 2282 | 0.060 |
Why?
|
Dyspareunia | 1 | 2003 | 50 | 0.050 |
Why?
|
Health Expenditures | 1 | 2015 | 2348 | 0.050 |
Why?
|
Diagnosis, Differential | 4 | 2007 | 12959 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.050 |
Why?
|
Androstenes | 1 | 2003 | 170 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3309 | 0.050 |
Why?
|
Cervical Intraepithelial Neoplasia | 1 | 2001 | 7 | 0.050 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1205 | 0.050 |
Why?
|
Pharyngeal Diseases | 1 | 1983 | 133 | 0.050 |
Why?
|
Contraceptive Agents | 1 | 2003 | 151 | 0.050 |
Why?
|
Exercise | 2 | 2002 | 5615 | 0.050 |
Why?
|
Genital Diseases, Female | 2 | 1980 | 197 | 0.050 |
Why?
|
Pulmonary Medicine | 1 | 2003 | 213 | 0.050 |
Why?
|
Papillomavirus Infections | 3 | 2003 | 1587 | 0.050 |
Why?
|
Health Status | 1 | 2015 | 4034 | 0.050 |
Why?
|
Laparoscopy | 5 | 1999 | 2151 | 0.050 |
Why?
|
Statistics, Nonparametric | 3 | 2001 | 2886 | 0.050 |
Why?
|
Folic Acid Deficiency | 2 | 1996 | 115 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2000 | 703 | 0.050 |
Why?
|
Observer Variation | 2 | 2014 | 2593 | 0.050 |
Why?
|
Suburban Population | 2 | 1992 | 55 | 0.050 |
Why?
|
Immunization Schedule | 1 | 2001 | 221 | 0.040 |
Why?
|
Sexual Abstinence | 1 | 1999 | 16 | 0.040 |
Why?
|
Adnexal Diseases | 1 | 1980 | 102 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11725 | 0.040 |
Why?
|
Clinical Competence | 2 | 2018 | 4687 | 0.040 |
Why?
|
Bottle Feeding | 1 | 1999 | 66 | 0.040 |
Why?
|
Ego | 1 | 1999 | 96 | 0.040 |
Why?
|
Career Choice | 3 | 2018 | 744 | 0.040 |
Why?
|
Sports | 2 | 1984 | 688 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2297 | 0.040 |
Why?
|
Awards and Prizes | 2 | 2017 | 375 | 0.040 |
Why?
|
Pregnancy Tests | 1 | 1998 | 30 | 0.040 |
Why?
|
Iron | 1 | 2007 | 1774 | 0.040 |
Why?
|
Contraceptives, Postcoital | 1 | 1998 | 16 | 0.040 |
Why?
|
Self-Assessment | 1 | 2001 | 390 | 0.040 |
Why?
|
Psychological Theory | 1 | 1999 | 168 | 0.040 |
Why?
|
Pregnancy, Unwanted | 1 | 1998 | 26 | 0.040 |
Why?
|
Bone Resorption | 1 | 2002 | 723 | 0.040 |
Why?
|
Seasons | 1 | 2004 | 1493 | 0.040 |
Why?
|
Appointments and Schedules | 2 | 1999 | 417 | 0.040 |
Why?
|
Child Behavior | 2 | 2001 | 839 | 0.040 |
Why?
|
Weight Gain | 1 | 2008 | 2292 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2008 | 2038 | 0.040 |
Why?
|
Anemia, Megaloblastic | 2 | 1996 | 25 | 0.040 |
Why?
|
Prospective Studies | 9 | 2010 | 53288 | 0.040 |
Why?
|
Socioeconomic Factors | 4 | 2017 | 7785 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2009 | 39050 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6489 | 0.040 |
Why?
|
Glucose Intolerance | 1 | 2002 | 577 | 0.040 |
Why?
|
Family Planning Services | 1 | 2000 | 263 | 0.040 |
Why?
|
Fallopian Tube Neoplasms | 1 | 1980 | 324 | 0.040 |
Why?
|
Plants, Toxic | 1 | 1997 | 76 | 0.040 |
Why?
|
Bulimia | 1 | 2000 | 382 | 0.040 |
Why?
|
Risk Factors | 7 | 2011 | 72290 | 0.040 |
Why?
|
Anemia | 1 | 2007 | 1506 | 0.040 |
Why?
|
World Health Organization | 1 | 2003 | 1318 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 2004 | 1801 | 0.040 |
Why?
|
Crime | 1 | 1998 | 215 | 0.040 |
Why?
|
Personnel Turnover | 1 | 2017 | 83 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2000 | 553 | 0.040 |
Why?
|
Algorithms | 2 | 2014 | 13881 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2000 | 1144 | 0.040 |
Why?
|
Professional Autonomy | 1 | 2018 | 177 | 0.040 |
Why?
|
Nonprescription Drugs | 1 | 1997 | 116 | 0.040 |
Why?
|
Focus Groups | 2 | 2018 | 1321 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2003 | 1405 | 0.040 |
Why?
|
Androgens | 4 | 1999 | 1281 | 0.040 |
Why?
|
Educational Status | 2 | 2002 | 2540 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2003 | 1063 | 0.030 |
Why?
|
Time Factors | 7 | 2017 | 40075 | 0.030 |
Why?
|
Migraine Disorders | 1 | 2008 | 1620 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2000 | 3508 | 0.030 |
Why?
|
Prevalence | 4 | 2004 | 15226 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 2872 | 0.030 |
Why?
|
Venous Thromboembolism | 1 | 2008 | 1671 | 0.030 |
Why?
|
Social Class | 2 | 1999 | 1999 | 0.030 |
Why?
|
Child, Preschool | 9 | 2009 | 41006 | 0.030 |
Why?
|
Leuprolide | 1 | 1997 | 321 | 0.030 |
Why?
|
Vitamins | 1 | 2004 | 1622 | 0.030 |
Why?
|
Japan | 1 | 2000 | 1360 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1070 | 0.030 |
Why?
|
17-Ketosteroids | 2 | 1988 | 39 | 0.030 |
Why?
|
Anti-Bacterial Agents | 3 | 1993 | 7181 | 0.030 |
Why?
|
Alcoholic Beverages | 1 | 1997 | 265 | 0.030 |
Why?
|
Syphilis | 1 | 1998 | 227 | 0.030 |
Why?
|
Vitamin B 12 Deficiency | 1 | 1996 | 116 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2001 | 6365 | 0.030 |
Why?
|
Urban Population | 3 | 2001 | 2021 | 0.030 |
Why?
|
Specialty Boards | 1 | 2017 | 227 | 0.030 |
Why?
|
Osteogenesis | 1 | 2002 | 1299 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2000 | 840 | 0.030 |
Why?
|
Cervix Uteri | 1 | 1999 | 590 | 0.030 |
Why?
|
Bone Remodeling | 1 | 1999 | 575 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2000 | 838 | 0.030 |
Why?
|
Conscious Sedation | 1 | 1999 | 528 | 0.030 |
Why?
|
Puberty, Precocious | 1 | 1996 | 156 | 0.030 |
Why?
|
Estradiol Congeners | 1 | 1994 | 28 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2023 | 1419 | 0.030 |
Why?
|
Reagent Strips | 2 | 1987 | 39 | 0.030 |
Why?
|
Behavior | 1 | 1997 | 561 | 0.030 |
Why?
|
Public Housing | 1 | 1995 | 145 | 0.030 |
Why?
|
Urination Disorders | 2 | 1987 | 241 | 0.030 |
Why?
|
Dietary Supplements | 2 | 2004 | 3297 | 0.030 |
Why?
|
Sex Counseling | 1 | 1993 | 17 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2018 | 643 | 0.030 |
Why?
|
Pain | 5 | 1999 | 4986 | 0.030 |
Why?
|
Choice Behavior | 1 | 1999 | 803 | 0.030 |
Why?
|
Aggression | 1 | 1998 | 753 | 0.030 |
Why?
|
Video Recording | 1 | 1998 | 949 | 0.030 |
Why?
|
Anabolic Agents | 1 | 1995 | 247 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4262 | 0.030 |
Why?
|
Body Height | 2 | 1993 | 1577 | 0.030 |
Why?
|
Attitude | 1 | 1997 | 776 | 0.030 |
Why?
|
Probability | 1 | 1998 | 2505 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2000 | 1826 | 0.030 |
Why?
|
Child Development | 2 | 2001 | 2223 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2000 | 1670 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
Nutrition Disorders | 1 | 1993 | 211 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2000 | 7279 | 0.030 |
Why?
|
Physician's Role | 2 | 1999 | 943 | 0.030 |
Why?
|
Religion | 1 | 2015 | 356 | 0.030 |
Why?
|
Education, Medical, Undergraduate | 1 | 2000 | 1008 | 0.030 |
Why?
|
Critical Pathways | 1 | 1995 | 476 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2007 | 15540 | 0.020 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 1991 | 98 | 0.020 |
Why?
|
Health Surveys | 1 | 2001 | 4037 | 0.020 |
Why?
|
Homosexuality | 1 | 1991 | 262 | 0.020 |
Why?
|
Regression Analysis | 3 | 2002 | 6459 | 0.020 |
Why?
|
Cannabis | 1 | 1997 | 439 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2000 | 2107 | 0.020 |
Why?
|
Breast Feeding | 1 | 1999 | 1338 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2003 | 3589 | 0.020 |
Why?
|
Osteocalcin | 2 | 2002 | 273 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2015 | 77449 | 0.020 |
Why?
|
Specialization | 1 | 1995 | 777 | 0.020 |
Why?
|
Emergency Medical Services | 2 | 1999 | 1917 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 2682 | 0.020 |
Why?
|
Bone Development | 1 | 1993 | 483 | 0.020 |
Why?
|
Hospitals, University | 1 | 2011 | 571 | 0.020 |
Why?
|
Aftercare | 1 | 1995 | 866 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 1997 | 2765 | 0.020 |
Why?
|
Gender Identity | 1 | 1995 | 688 | 0.020 |
Why?
|
Memory Disorders | 1 | 1996 | 1184 | 0.020 |
Why?
|
Recurrence | 1 | 2001 | 8340 | 0.020 |
Why?
|
Photography | 1 | 1992 | 520 | 0.020 |
Why?
|
Office Visits | 1 | 1993 | 598 | 0.020 |
Why?
|
Mothers | 1 | 1999 | 2165 | 0.020 |
Why?
|
Hypertension | 1 | 2008 | 8480 | 0.020 |
Why?
|
Smoking | 4 | 1997 | 8987 | 0.020 |
Why?
|
Vulvitis | 1 | 1987 | 8 | 0.020 |
Why?
|
Medical Records | 2 | 2008 | 1413 | 0.020 |
Why?
|
Primary Health Care | 1 | 2004 | 4558 | 0.020 |
Why?
|
Forecasting | 1 | 2017 | 2951 | 0.020 |
Why?
|
Students | 1 | 1997 | 1654 | 0.020 |
Why?
|
Achievement | 1 | 2009 | 291 | 0.020 |
Why?
|
Infant | 4 | 2009 | 35136 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2001 | 3022 | 0.020 |
Why?
|
Communication | 1 | 2001 | 3749 | 0.020 |
Why?
|
Alkaline Phosphatase | 2 | 2002 | 865 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2000 | 3188 | 0.020 |
Why?
|
Lymphogranuloma Venereum | 1 | 1987 | 13 | 0.020 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 1987 | 25 | 0.020 |
Why?
|
Decision Making | 2 | 2018 | 3887 | 0.020 |
Why?
|
Trichomonas Vaginitis | 1 | 1987 | 35 | 0.020 |
Why?
|
Academies and Institutes | 1 | 1989 | 317 | 0.020 |
Why?
|
Haemophilus Infections | 1 | 1987 | 95 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 23338 | 0.020 |
Why?
|
Risk | 2 | 2015 | 9687 | 0.020 |
Why?
|
Condylomata Acuminata | 1 | 1987 | 82 | 0.020 |
Why?
|
Scoliosis | 1 | 1993 | 725 | 0.020 |
Why?
|
Chronic Disease | 2 | 1998 | 9146 | 0.020 |
Why?
|
Reference Values | 1 | 1994 | 4982 | 0.020 |
Why?
|
Medicine | 1 | 1995 | 946 | 0.020 |
Why?
|
Computer Security | 1 | 2008 | 262 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2002 | 3336 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 1993 | 1151 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12745 | 0.020 |
Why?
|
Diet | 1 | 2004 | 7939 | 0.020 |
Why?
|
Organizational Policy | 1 | 2008 | 429 | 0.020 |
Why?
|
Metronidazole | 1 | 1987 | 217 | 0.020 |
Why?
|
Herpes Genitalis | 1 | 1987 | 141 | 0.020 |
Why?
|
Interferons | 1 | 1989 | 706 | 0.020 |
Why?
|
Animals | 2 | 2023 | 168757 | 0.020 |
Why?
|
Pilot Projects | 4 | 2001 | 8324 | 0.020 |
Why?
|
Workload | 1 | 2011 | 850 | 0.020 |
Why?
|
Bone Diseases, Metabolic | 1 | 1989 | 417 | 0.020 |
Why?
|
Weight Loss | 1 | 1996 | 2622 | 0.020 |
Why?
|
Urinary Tract Infections | 2 | 1982 | 788 | 0.020 |
Why?
|
Pituitary Hormone-Releasing Hormones | 1 | 1984 | 41 | 0.020 |
Why?
|
Gonadal Dysgenesis | 1 | 1984 | 30 | 0.020 |
Why?
|
Aging | 1 | 2003 | 8664 | 0.020 |
Why?
|
Physical Exertion | 2 | 1984 | 695 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2124 | 0.020 |
Why?
|
Fluorouracil | 1 | 1989 | 1619 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 1990 | 1725 | 0.020 |
Why?
|
Health Policy | 1 | 2017 | 2661 | 0.020 |
Why?
|
Students, Medical | 1 | 2017 | 1862 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1770 | 0.020 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1983 | 80 | 0.010 |
Why?
|
Testosterone | 2 | 1988 | 2420 | 0.010 |
Why?
|
Public Health | 1 | 1997 | 2603 | 0.010 |
Why?
|
Substance-Related Disorders | 2 | 1998 | 4258 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1993 | 2232 | 0.010 |
Why?
|
Hydroxyprogesterones | 1 | 1983 | 25 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1987 | 1588 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1980 | 4838 | 0.010 |
Why?
|
Hypothalamus | 1 | 1989 | 1063 | 0.010 |
Why?
|
Turner Syndrome | 1 | 1984 | 130 | 0.010 |
Why?
|
Energy Intake | 2 | 2002 | 2148 | 0.010 |
Why?
|
Estradiol | 2 | 2002 | 2020 | 0.010 |
Why?
|
Dancing | 1 | 1984 | 101 | 0.010 |
Why?
|
Follicular Phase | 1 | 1983 | 153 | 0.010 |
Why?
|
Ovarian Diseases | 1 | 1984 | 139 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2373 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2002 | 2015 | 0.010 |
Why?
|
Depressive Disorder | 1 | 1995 | 3748 | 0.010 |
Why?
|
Laser Therapy | 1 | 1989 | 1072 | 0.010 |
Why?
|
Ethinyl Estradiol | 1 | 2002 | 116 | 0.010 |
Why?
|
Prolactin | 1 | 1984 | 669 | 0.010 |
Why?
|
Antifungal Agents | 1 | 1987 | 730 | 0.010 |
Why?
|
Disabled Persons | 1 | 1991 | 1212 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2002 | 238 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2014 | 21746 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 2000 | 4933 | 0.010 |
Why?
|
American Medical Association | 1 | 2001 | 65 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5985 | 0.010 |
Why?
|
Hospitalization | 2 | 2017 | 10262 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2014 | 19905 | 0.010 |
Why?
|
Gonadotropins, Pituitary | 1 | 1980 | 73 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 1996 | 3658 | 0.010 |
Why?
|
Depression | 1 | 2000 | 7766 | 0.010 |
Why?
|
Research | 1 | 2009 | 1999 | 0.010 |
Why?
|
Sickle Cell Trait | 1 | 1980 | 81 | 0.010 |
Why?
|
Cohort Studies | 1 | 2003 | 40561 | 0.010 |
Why?
|
Uterus | 1 | 1984 | 711 | 0.010 |
Why?
|
Adrenal Gland Diseases | 1 | 1980 | 138 | 0.010 |
Why?
|
Running | 1 | 1984 | 480 | 0.010 |
Why?
|
Societies, Medical | 1 | 1991 | 3743 | 0.010 |
Why?
|
Collagen Type I | 1 | 2002 | 592 | 0.010 |
Why?
|
Teaching Materials | 1 | 1999 | 86 | 0.010 |
Why?
|
Heart Rate | 2 | 2001 | 4091 | 0.010 |
Why?
|
Patient Participation | 1 | 2008 | 1457 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 2002 | 1150 | 0.010 |
Why?
|
Firearms | 2 | 1997 | 598 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5319 | 0.010 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1984 | 740 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 1979 | 277 | 0.010 |
Why?
|
Endocrine System Diseases | 1 | 1980 | 248 | 0.010 |
Why?
|
Family Practice | 1 | 2001 | 516 | 0.010 |
Why?
|
Vermont | 1 | 1998 | 85 | 0.010 |
Why?
|
HLA Antigens | 1 | 1983 | 1381 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4215 | 0.010 |
Why?
|
Body Image | 1 | 2002 | 610 | 0.010 |
Why?
|
Asthma | 1 | 1996 | 6011 | 0.010 |
Why?
|
Erotica | 1 | 1997 | 22 | 0.010 |
Why?
|
Prognosis | 2 | 2000 | 29063 | 0.010 |
Why?
|
Laparotomy | 1 | 1979 | 473 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2001 | 2031 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1979 | 981 | 0.010 |
Why?
|
Acanthosis Nigricans | 1 | 1996 | 48 | 0.010 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 1996 | 63 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 1998 | 477 | 0.010 |
Why?
|
Food | 1 | 2001 | 771 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1997 | 552 | 0.010 |
Why?
|
Suicide | 2 | 1998 | 1477 | 0.010 |
Why?
|
Folic Acid | 1 | 1982 | 1300 | 0.010 |
Why?
|
Adolescent, Hospitalized | 1 | 1995 | 31 | 0.010 |
Why?
|
Posture | 1 | 1980 | 958 | 0.010 |
Why?
|
Seat Belts | 1 | 1995 | 57 | 0.010 |
Why?
|
Age Distribution | 1 | 2001 | 2902 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 1984 | 1345 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2001 | 933 | 0.010 |
Why?
|
Motorcycles | 1 | 1995 | 44 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1420 | 0.010 |
Why?
|
Forms and Records Control | 1 | 1995 | 160 | 0.010 |
Why?
|
Gynecologic Surgical Procedures | 1 | 1998 | 336 | 0.010 |
Why?
|
Platelet Count | 1 | 1997 | 781 | 0.010 |
Why?
|
Referral and Consultation | 2 | 1999 | 3528 | 0.010 |
Why?
|
Brain | 1 | 2001 | 26385 | 0.010 |
Why?
|
Head Protective Devices | 1 | 1995 | 114 | 0.010 |
Why?
|
Adipose Tissue | 2 | 2002 | 3279 | 0.010 |
Why?
|
Gynecology | 1 | 1980 | 513 | 0.010 |
Why?
|
Abortion, Legal | 1 | 1995 | 116 | 0.010 |
Why?
|
Crime Victims | 1 | 1998 | 322 | 0.010 |
Why?
|
Collagen | 1 | 2002 | 2689 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1979 | 1681 | 0.010 |
Why?
|
Alcohol Drinking | 2 | 1997 | 3966 | 0.010 |
Why?
|
Body Composition | 1 | 2002 | 2401 | 0.010 |
Why?
|
Nutrition Assessment | 1 | 1996 | 723 | 0.010 |
Why?
|
Functional Laterality | 1 | 2000 | 2290 | 0.010 |
Why?
|
Middle Aged | 3 | 2017 | 213383 | 0.010 |
Why?
|
Random Allocation | 1 | 1997 | 2429 | 0.010 |
Why?
|
Abortion, Induced | 1 | 1998 | 458 | 0.010 |
Why?
|
Leptin | 1 | 2000 | 1599 | 0.010 |
Why?
|
Stress, Psychological | 2 | 1984 | 4245 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4669 | 0.010 |
Why?
|
HIV Infections | 1 | 1998 | 16718 | 0.010 |
Why?
|
Acne Vulgaris | 1 | 1996 | 302 | 0.010 |
Why?
|
Methods | 1 | 1991 | 1129 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2001 | 2731 | 0.010 |
Why?
|
Administration, Oral | 1 | 1999 | 3913 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 1681 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 1998 | 1425 | 0.010 |
Why?
|
Peptides | 1 | 2002 | 4409 | 0.010 |
Why?
|
Age of Onset | 1 | 1997 | 3271 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1983 | 5391 | 0.010 |
Why?
|
Automobile Driving | 1 | 1995 | 431 | 0.010 |
Why?
|
Life Change Events | 1 | 1995 | 938 | 0.010 |
Why?
|
Preoperative Care | 1 | 1998 | 2250 | 0.010 |
Why?
|
Motivation | 1 | 1999 | 1971 | 0.010 |
Why?
|
Leukemia | 1 | 1997 | 1511 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1989 | 25625 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12245 | 0.010 |
Why?
|
Lymphoma | 1 | 1997 | 1877 | 0.000 |
Why?
|
Interview, Psychological | 1 | 1991 | 812 | 0.000 |
Why?
|
Cytokines | 1 | 2002 | 7322 | 0.000 |
Why?
|
Clinical Protocols | 1 | 1993 | 1462 | 0.000 |
Why?
|
Length of Stay | 1 | 2000 | 6309 | 0.000 |
Why?
|
Medicaid | 1 | 1979 | 2736 | 0.000 |
Why?
|
Blood Glucose | 1 | 2000 | 6256 | 0.000 |
Why?
|
Physician-Patient Relations | 1 | 1999 | 3229 | 0.000 |
Why?
|
Cost of Illness | 1 | 1995 | 1859 | 0.000 |
Why?
|
Insulin | 1 | 2000 | 6580 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 6038 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5708 | 0.000 |
Why?
|
Anxiety, Separation | 1 | 1984 | 86 | 0.000 |
Why?
|
Registries | 1 | 2000 | 8089 | 0.000 |
Why?
|
Family | 1 | 1995 | 3147 | 0.000 |
Why?
|
Premenstrual Syndrome | 1 | 1984 | 109 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2000 | 63114 | 0.000 |
Why?
|
Dysmenorrhea | 1 | 1984 | 86 | 0.000 |
Why?
|
Karyotyping | 1 | 1984 | 1243 | 0.000 |
Why?
|
Ferritins | 1 | 1982 | 590 | 0.000 |
Why?
|
Body Mass Index | 1 | 1996 | 12720 | 0.000 |
Why?
|